Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion Reports Q3 2024 Preliminary Revenue of KRW 881.9B and Operating Profit of KRW 207.7B (068270)

Posted on November 8, 2024July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion Reports Q3 2024 Preliminary Revenue of KRW 881.9B and Operating Profit of KRW 207.7B (068270)

Source Facts: Financial Supervisory Service Electronic Disclosure System (DART) / 2024-11-08

Disclosure Type: Preliminary Earnings Release (Consolidated) (Fair Disclosure)

💡 3-Second Summary

On a consolidated basis, Celltrion’s preliminary Q3 2024 revenue reached KRW 881.9B, up 31.18% year-over-year, while operating profit rose 186.51% quarter-over-quarter to KRW 207.7B, despite a 22.40% decrease compared to the same period last year.

📊 1. [Key Disclosure Content & Major Financial Figures Summary]

  • Q3 (Current Quarter) Earnings & Growth Rates (Unit: KRW Million, %):
    • Revenue: KRW 881,933 million (Quarter-over-Quarter: +0.82% / Year-over-Year: +31.18%)
    • Operating Profit: KRW 207,686 million (Quarter-over-Quarter: +186.51% / Year-over-Year: -22.40%)
    • Income Before Income Taxes: KRW 178,249 million (Quarter-over-Quarter: +71.07% / Year-over-Year: -36.99%)
    • Net Income: KRW 84,094 million (Quarter-over-Quarter: +7.19% / Year-over-Year: -61.99%)
    • Net Income Attributable to Controlling Interest: KRW 85,593 million (Quarter-over-Quarter: +9.72% / Year-over-Year: -61.41%)
  • Q3 Cumulative (YTD) Earnings & Growth Rates:
    • Cumulative Revenue: KRW 2,493,655 million (Year-over-Year: +39.01%)
    • Cumulative Operating Profit: KRW 295,612 million (Year-over-Year: -53.30%)
    • Cumulative Income Before Income Taxes: KRW 302,124 million (Year-over-Year: -55.63%)
    • Cumulative Net Income: KRW 183,314 million (Year-over-Year: -66.01%)
    • Cumulative Net Income Attributable to Controlling Interest: KRW 186,043 million (Year-over-Year: -65.20%)
  • Disclosure Information Details:
    • Date and Provider: November 8, 2024 / Celltrion IR Team
    • Target Audience: Domestic and international investors, media outlets, etc.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This filing is a fair disclosure presenting Celltrion’s preliminary consolidated financial results for the third quarter and cumulative nine-month period of 2024, prior to the completion of the external audit.

From a financial perspective, there is a clear divergence between top-line expansion and bottom-line profit metrics. Third-quarter revenue (approx. KRW 881.9B) maintained upward momentum both quarter-over-quarter and year-over-year, leading to a cumulative revenue increase of 39.01% (approx. KRW 2.49T). Conversely, although Q3 operating profit (approx. KRW 207.7B) recovered sharply by 186.51% compared to the previous quarter (approx. KRW 72.5B), it registered a 22.40% contraction compared to Q3 2023. Furthermore, cumulative YTD operating profit (approx. KRW 295.6B) and net income (approx. KRW 183.3B) represent significant declines of 53.30% and 66.01%, respectively, compared to the same period in 2023. These preliminary calculations are subject to change pending the final audited outcomes from the external auditor.

📝 Editor’s Comment (by K-STOCK Editor)

This fair disclosure registers preliminary, non-audited financial results for the third quarter of 2024 to provide timely marketplace communication. The central established fact is that despite strong year-to-date revenue growth, cumulative operating and net profit figures have decreased by over half compared to the prior-year period.

Investors must recognize that these metrics represent unaudited internal calculations and are not finalized. The figures remain subject to adjustments once the external auditor completes the official review and finalizes the quarterly accounts. Additionally, this specific filing outlines only consolidated summary totals and does not break down divisional revenue contributions, cost of goods sold, or operational expenditures.

Consequently, the objective checkpoints for investors to monitor going forward are twofold: first, the official publication of the finalized “Quarterly Report,” verifying whether any discrepancies exist between the preliminary figures and the audited financial statements; and second, the subsequent verification of detailed expense structures and operational drivers in the official IR materials published on the corporate website. Cross-referencing these finalized documents is the necessary pathway to verifying the company’s true financial performance.

📢 Disclaimer & Source Information

Source: This content has been structured and newly drafted based on official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest solely with the investor.

Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Bio & Healthcare, Disclosures

Post navigation

Previous Post: [Disclosure] Celltrion to List 57,364 Additional Common Shares Following Stock Option Exercise (068270)
Next Post: [Disclosure] Celltrion Reports Q3 2024 Preliminary Separate Revenue of KRW 1.04T and Operating Profit of KRW 461.7B (068270)

Related Posts

[Disclosure] SK hynix (000660) Publishes 2024 Sustainability Report, Aligning ‘AI First Mover’ Performance with Global ESG Frameworks Semiconductors
[Disclosure] Wonik IPS (Ticker: 240810) to Pay KRW 50 Cash Dividend, Building ‘Semiconductor Dream Team’ Board with Ex-Samsung & Hynix Executives Semiconductors
[Disclosure] Samsung Biologics(207940) Schedules Q1 2024 Earnings Release for April 24 Disclosures
[Disclosure] Hanwha Aerospace (012450) Amends Guided Weapons Supply Contract: Contract End Date Confirmed as Oct 7, 2028 Following L/C Issuance Disclosures
[Disclosure] LEENO Industrial (058470) Declares Year-End Cash Dividend of ₩3,000/Share… Total ₩45.5B Payout Showcases Peerless Cash-Generating Power Semiconductors
[Disclosure] Hanwha Aerospace (012450) – Contract Signed with PPS for Next-Generation Launch Vehicle Development Project (KRW 950.5B) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme